메뉴 건너뛰기




Volumn 35, Issue 4, 2014, Pages 3405-3408

Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma

Author keywords

Liver cancer; Radiofrequency ablation; Survival rate; Transarterial chemoembolization

Indexed keywords

ARTICLE; CHEMOEMBOLIZATION; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; PUBLISHING; RADIOFREQUENCY ABLATION; SENSITIVITY ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW;

EID: 84898818648     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1449-9     Document Type: Article
Times cited : (16)

References (31)
  • 1
    • 7044229778 scopus 로고    scopus 로고
    • Primary liver cancer: Worldwide incidence and trends
    • 15508102 10.1053/j.gastro.2004.09.011
    • Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5-S16.
    • (2004) Gastroenterology , vol.127
    • Bosch, F.X.1    Ribes, J.2    Díaz, M.3    Cléries, R.4
  • 2
    • 7044272630 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
    • 15508101 10.1053/j.gastro.2004.09.014
    • Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35-50.
    • (2004) Gastroenterology , vol.127
    • Fattovich, G.1    Stroffolini, T.2    Zagni, I.3    Donato, F.4
  • 3
    • 79960748644 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
    • 1:STN:280:DC%2BC3MjhtlylsA%3D%3D 21766289 10.1002/bjs.7669
    • Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98:1210-24.
    • (2011) Br J Surg , vol.98 , pp. 1210-1224
    • Tiong, L.1    Maddern, G.J.2
  • 4
    • 0033620786 scopus 로고    scopus 로고
    • Percutaneous radiofrequency thermal ablation for liver tumours
    • 1:STN:280:DyaK1MzmsVKisA%3D%3D 10437901 10.1016/S0140-6736(05)75847-5
    • Jiao LR. Percutaneous radiofrequency thermal ablation for liver tumours. Lancet. 1999;354:427-8.
    • (1999) Lancet , vol.354 , pp. 427-428
    • Jiao, L.R.1
  • 5
    • 0033947630 scopus 로고    scopus 로고
    • Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
    • 1:STN:280:DC%2BD3czitVCrug%3D%3D 1421103 10862190 10.1097/00000658- 200007000-00003
    • Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24.
    • (2000) Ann Surg , vol.232 , pp. 10-24
    • Tung-Ping Poon, R.1    Fan, S.T.2    Wong, J.3
  • 6
    • 77955699976 scopus 로고    scopus 로고
    • Loco-regional treatment of hepatocellular carcinoma
    • 1:CAS:528:DC%2BC3cXhtV2ju7fF 20564355 10.1002/hep.23725
    • Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology. 2010;52:762-73.
    • (2010) Hepatology , vol.52 , pp. 762-773
    • Lencioni, R.1
  • 7
    • 25844434766 scopus 로고    scopus 로고
    • Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC
    • 16201083
    • Shen SQ, Xiang JJ, Xiong CL, Wu SM, Zhu SS. Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology. 2005;52:1403-7.
    • (2005) Hepatogastroenterology , vol.52 , pp. 1403-1407
    • Shen, S.Q.1    Xiang, J.J.2    Xiong, C.L.3    Wu, S.M.4    Zhu, S.S.5
  • 8
  • 9
    • 34548077483 scopus 로고    scopus 로고
    • Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation
    • 16004809
    • Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation. Ai Zheng. 2005;24:827-33.
    • (2005) Ai Zheng , vol.24 , pp. 827-833
    • Wang, Y.B.1    Chen, M.H.2    Yan, K.3    Yang, W.4    Dai, Y.5    Yin, S.S.6
  • 10
    • 41949133133 scopus 로고    scopus 로고
    • Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: A randomized controlled trial
    • 1:CAS:528:DC%2BD1cXks1Wmtrw%3D 18398079 10.1001/jama.299.14.1669
    • Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299:1669-77.
    • (2008) JAMA , vol.299 , pp. 1669-1677
    • Cheng, B.Q.1    Jia, C.Q.2    Liu, C.T.3    Fan, W.4    Wang, Q.L.5    Zhang, Z.L.6
  • 11
    • 77954360953 scopus 로고    scopus 로고
    • Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma
    • 10.1002/hep.21398
    • Aikata H, Shirakawa H, Takaki S. Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma. Hepatology. 2006;44:A487.
    • (2006) Hepatology , vol.44 , pp. 487
    • Aikata, H.1    Shirakawa, H.2    Takaki, S.3
  • 12
    • 58749105130 scopus 로고    scopus 로고
    • Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC
    • 1:CAS:528:DC%2BD1cXhsV2ksbjO 18670743 10.1007/s12325-008-0079-x
    • Yang P, Liang M, Zhang Y, Shen B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv Ther. 2008;25:787-94.
    • (2008) Adv Ther , vol.25 , pp. 787-794
    • Yang, P.1    Liang, M.2    Zhang, Y.3    Shen, B.4
  • 13
    • 65849306698 scopus 로고    scopus 로고
    • Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy
    • 19094753
    • Xu L, Li P, Chen MS, Pang XH, Gao HJ, Peng ZW, et al. Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy. Zhonghua Wai Ke Za Zhi. 2008;46:1617-20.
    • (2008) Zhonghua Wai Ke Za Zhi , vol.46 , pp. 1617-1620
    • Xu, L.1    Li, P.2    Chen, M.S.3    Pang, X.H.4    Gao, H.J.5    Peng, Z.W.6
  • 14
    • 69249212586 scopus 로고    scopus 로고
    • Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment
    • 1:CAS:528:DC%2BD1MXktlKqsrw%3D 19054154 10.1111/j.1872-034X.2008.00451.x
    • Yang W, Chen MH, Wang MQ, Cui M, Gao W, Wu W, et al. Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res. 2009;39:231-40.
    • (2009) Hepatol Res , vol.39 , pp. 231-240
    • Yang, W.1    Chen, M.H.2    Wang, M.Q.3    Cui, M.4    Gao, W.5    Wu, W.6
  • 15
    • 76449106934 scopus 로고    scopus 로고
    • A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma
    • 19643561 10.1016/j.ejso.2009.07.007
    • Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, et al. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Eur J Surg Oncol. 2010;36:257-63.
    • (2010) Eur J Surg Oncol , vol.36 , pp. 257-263
    • Peng, Z.W.1    Chen, M.S.2    Liang, H.H.3    Gao, H.J.4    Zhang, Y.J.5    Li, J.Q.6
  • 16
    • 84871618704 scopus 로고    scopus 로고
    • Radiofrequency ablation and transcatheter arterial chemoembolization in primary hepatic carcinoma
    • Hu YQ. Radiofrequency ablation and transcatheter arterial chemoembolization in primary hepatic carcinoma. Contemp Med. 2011;17:232-3.
    • (2011) Contemp Med , vol.17 , pp. 232-233
    • Hu, Y.Q.1
  • 17
    • 84856951551 scopus 로고    scopus 로고
    • Hepatocellular carcinomas 2-3 cm in diameter: Transarterial chemoembolization plus radiofrequency ablation vs radiofrequency ablation alone
    • 21353417 10.1016/j.ejrad.2011.01.122
    • Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, et al. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol. 2012;81:e189-93.
    • (2012) Eur J Radiol , vol.81
    • Kim, J.W.1    Kim, J.H.2    Won, H.J.3    Shin, Y.M.4    Yoon, H.K.5    Sung, K.B.6
  • 18
    • 79956199426 scopus 로고    scopus 로고
    • Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: Transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone
    • 21445671 10.1245/s10434-011-1673-8
    • Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, et al. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol. 2011;18:1624-9.
    • (2011) Ann Surg Oncol , vol.18 , pp. 1624-1629
    • Kim, J.H.1    Won, H.J.2    Shin, Y.M.3    Kim, S.H.4    Yoon, H.K.5    Sung, K.B.6
  • 19
    • 84871622548 scopus 로고    scopus 로고
    • Therapy of 3-dimension conformal technology guided radiofrequency ablation and trascatheter arterial chemoembolizatlon in primary hepatic carcinoma
    • 1:CAS:528:DC%2BD1MXivVelug%3D%3D
    • Luo ZG, Xiong K, Duan QW, Ren JM, Wang DW, Li C. Therapy of 3-dimension conformal technology guided radiofrequency ablation and trascatheter arterial chemoembolizatlon in primary hepatic carcinoma. Yunyang Yi Xue Yuan Xue Bao. 2008;27:22-5.
    • (2008) Yunyang Yi Xue Yuan Xue Bao , vol.27 , pp. 22-25
    • Luo, Z.G.1    Xiong, K.2    Duan, Q.W.3    Ren, J.M.4    Wang, D.W.5    Li, C.6
  • 20
    • 77952970191 scopus 로고    scopus 로고
    • Radiofrequency ablation with or without transcatheter arterial chemoembolization for management of hepatocellular carcinoma
    • 18024306
    • Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization for management of hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27:1749-51.
    • (2007) Nan Fang Yi Ke da Xue Xue Bao , vol.27 , pp. 1749-1751
    • Li, Z.R.1    Kang, Z.2    Qian, J.S.3    Zhu, K.S.4    Jiang, Z.B.5    Huang, M.S.6
  • 21
    • 70349283138 scopus 로고    scopus 로고
    • Small hepatocellular carcinoma: Is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    • 19567647 10.1148/radiol.2523081676
    • Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology. 2009;252:905-13.
    • (2009) Radiology , vol.252 , pp. 905-913
    • Shibata, T.1    Isoda, H.2    Hirokawa, Y.3    Arizono, S.4    Shimada, K.5    Togashi, K.6
  • 22
    • 84871621474 scopus 로고    scopus 로고
    • Clinical application of a combination therapy of percutaneous radiofrequency and transcatheter arterial chemoembolization in large hepatic tumors
    • Shen L, Chen MH, Yan K, Yang W, Gao W, Liao SR, et al. Clinical application of a combination therapy of percutaneous radiofrequency and transcatheter arterial chemoembolization in large hepatic tumors. Zhonghua Chao Sheng Yin Xiang Xue Za Zhi. 2004;13:577-80.
    • (2004) Zhonghua Chao Sheng Yin Xiang Xue Za Zhi , vol.13 , pp. 577-580
    • Shen, L.1    Chen, M.H.2    Yan, K.3    Yang, W.4    Gao, W.5    Liao, S.R.6
  • 23
    • 84871608378 scopus 로고    scopus 로고
    • Radiofrequency ablation or transcather arterial chemoembolization for management of hepatocellular carcinoma
    • 1:CAS:528:DC%2BD2sXhsVGrsb%2FM
    • Zhang HC, Liang J. Radiofrequency ablation or transcather arterial chemoembolization for management of hepatocellular carcinoma. Zhong Guo Yi Shi Jin Xiu Za Zhi. 2007;30:67-8.
    • (2007) Zhong Guo Yi Shi Jin Xiu Za Zhi , vol.30 , pp. 67-68
    • Zhang, H.C.1    Liang, J.2
  • 24
    • 84871614648 scopus 로고    scopus 로고
    • Transcather arterial chemoembolization combined with radiofrequency ablation for the management of hepatocellular carcinoma
    • Liang MH. Transcather arterial chemoembolization combined with radiofrequency ablation for the management of hepatocellular carcinoma. Zhong Guo Lao Nian Yi Xue Za Zhi. 2011;31:2862-4.
    • (2011) Zhong Guo Lao Nian Yi Xue Za Zhi , vol.31 , pp. 2862-2864
    • Liang, M.H.1
  • 25
    • 78649570066 scopus 로고    scopus 로고
    • Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization
    • 20672352 10.1002/cncr.25314
    • Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer. 2010;116:5452-60.
    • (2010) Cancer , vol.116 , pp. 5452-5460
    • Morimoto, M.1    Numata, K.2    Kondou, M.3    Nozaki, A.4    Morita, S.5    Tanaka, K.6
  • 26
    • 79951952372 scopus 로고    scopus 로고
    • GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
    • 21195583 10.1016/j.jclinepi.2010.04.026
    • Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383-94.
    • (2011) J Clin Epidemiol , vol.64 , pp. 383-394
    • Guyatt, G.1    Oxman, A.D.2    Akl, E.A.3    Kunz, R.4    Vist, G.5    Brozek, J.6
  • 27
    • 43049113533 scopus 로고    scopus 로고
    • GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
    • 2335261 18436948 10.1136/bmj.39489.470347.AD
    • Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.
    • (2008) BMJ , vol.336 , pp. 924-926
    • Guyatt, G.H.1    Oxman, A.D.2    Vist, G.E.3    Kunz, R.4    Falck-Ytter, Y.5    Alonso-Coello, P.6
  • 28
    • 84862232423 scopus 로고    scopus 로고
    • Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells
    • 3444337 22546345 10.1186/1756-9966-31-39
    • Li H, Song H, Luo J, Liang J, Zhao S, Su R. Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2012;31:39.
    • (2012) J Exp Clin Cancer Res , vol.31 , pp. 39
    • Li, H.1    Song, H.2    Luo, J.3    Liang, J.4    Zhao, S.5    Su, R.6
  • 29
    • 78650890426 scopus 로고    scopus 로고
    • Inhibition of telomerase activity by HDV ribozyme in cancers
    • 3024244 21208462 10.1186/1756-9966-30-1
    • Lu Y, Gu J, Jin D, Gao Y, Yuan M. Inhibition of telomerase activity by HDV ribozyme in cancers. J Exp Clin Cancer Res. 2011;30:1.
    • (2011) J Exp Clin Cancer Res , vol.30 , pp. 1
    • Lu, Y.1    Gu, J.2    Jin, D.3    Gao, Y.4    Yuan, M.5
  • 30
    • 84881504613 scopus 로고    scopus 로고
    • Clinical significance of NUCB2 mRNA expression in prostate cancer
    • 3751731 23958433 10.1186/1756-9966-32-56
    • Zhang H, Qi C, Li L, Luo F, Xu Y. Clinical significance of NUCB2 mRNA expression in prostate cancer. J Exp Clin Cancer Res. 2013;32:56.
    • (2013) J Exp Clin Cancer Res , vol.32 , pp. 56
    • Zhang, H.1    Qi, C.2    Li, L.3    Luo, F.4    Xu, Y.5
  • 31
    • 84879818817 scopus 로고    scopus 로고
    • CYP1B1 polymorphisms and susceptibility to prostate cancer: A meta-analysis
    • 1:CAS:528:DC%2BC3sXhtFOmtLzL 3701676 23861929 10.1371/journal.pone. 0068634
    • Zhang H, Li L, Xu Y. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis. PLoS One. 2013;8:e68634.
    • (2013) PLoS One , vol.8 , pp. 68634
    • Zhang, H.1    Li, L.2    Xu, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.